Form D — Verra Therapeutics, Inc.
0002111997-26-000001 · filed 2026-02-18
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $450,000
- Total sold
- $205,000
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Verra Therapeutics, Inc.
- CIK
- 2111997
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 1939 EAST SHORE DR. SUITE 5
LANSING, NY 14882 - Phone
- 607 227 6828
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher Lucas Prince · DirectorLansing, NY Find on LinkedIn ↗
-
Christopher Lucas Prince · Executive OfficerLansing, NY Find on LinkedIn ↗
-
Christopher Lucas Prince · DirectorLansing, NY Find on LinkedIn ↗
-
Jeffrey Calkins · DirectorLansing, NY Find on LinkedIn ↗
View original on SEC EDGAR.